COURTNEY MILLER-CHISM to Humans
This is a "connection" page, showing publications COURTNEY MILLER-CHISM has written about Humans.
Connection Strength
0.031
-
Clinical Outcomes and Patterns of Care Among Patients With Newly Diagnosed Classical Hodgkin Lymphoma in a Safety-Net Health System. Clin Lymphoma Myeloma Leuk. 2026 Jan; 26(1):e12-e20.e5.
Score: 0.006
-
Phase I / II trial of metformin as a chemo-radiosensitizer in a head and neck cancer patient population. Oral Oncol. 2023 10; 145:106536.
Score: 0.006
-
Persistent ethnicity-associated disparity in anti-tumor effectiveness of immune checkpoint inhibitors despite equal access. Cancer Res Commun. 2022 07 26; 2022.
Score: 0.005
-
Clinical Outcomes of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia in a County Hospital System. Clin Lymphoma Myeloma Leuk. 2021 11; 21(11):e895-e902.
Score: 0.005
-
Participation of African American Persons in Clinical Trials Supporting U.S. Food and Drug Administration Approval of Cancer Drugs. Ann Intern Med. 2020 08 18; 173(4):320-322.
Score: 0.004
-
Safety Analysis of Five Randomized Controlled Studies of Daratumumab in Patients With Multiple Myeloma. Clin Lymphoma Myeloma Leuk. 2020 09; 20(9):e579-e589.
Score: 0.004